MeSH tree: D27.505.696.422.750
Once-weekly cagrilintide, an amylin receptor agonist, plus semaglutide is efficacious for adults with type 2 diabetes inadequately controlled with diet and exercise, receiving metformin with or without a sodium glucose cotransporter ...
Jun 12, 2026
0
7
For adults with type 2 diabetes (T2D) not on insulin therapy (NIT), continuous glucose monitoring (CGM) is associated with a substantial reduction in glycated hemoglobin (HbA1c), according to a study presented at the annual ...
Jun 11, 2026
0
6
New research presented at the 63rd ERA Congress suggests that a widely used class of blood pressure medications may be associated with poorer kidney outcomes in people with type 2 diabetes (T2D), even among patients already ...
Jun 4, 2026
0
10
A clinical decision support system (CDSS) for chronic kidney disease (CKD) does not improve physician behavior or patient outcomes over a control intervention, according to a study published online May 8 in JAMA Network Open.
May 14, 2026
0
5
Older adults with type 2 diabetes face a difficult trade-off: they are among the most vulnerable to medication-related harms yet are often underrepresented in the clinical trials that guide treatment decisions. A new study ...
Apr 29, 2026
0
12
People who live with obesity are "tagging" a memory of being overweight on a key part of the immune system—leaving people with ongoing risk of obesity-related conditions years after losing weight, according to a 10-year-long ...
Apr 27, 2026
0
17
Metformin has a strong claim to being one of the most influential medicines of the past century. For decades, it has underpinned the treatment of type 2 diabetes, helped millions of people control their blood sugar, and inspired ...
Apr 20, 2026
0
6
Weight-loss injections that have become famous for helping people shed pounds may also help some patients with advanced cancer live longer when the disease has spread to the brain, according to a new study.
Mar 22, 2026
0
10
Prior authorization, a process that requires physicians to obtain approval from health care insurers before certain treatments are covered, may keep patients from filling prescriptions for two critical heart failure drugs, ...
Mar 11, 2026
0
6
A class of medications best known for treating diabetes and obesity may also reduce the risk of addiction—and help people who already have one, a new study shows.
Mar 5, 2026
0
8
